Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
2seventy bio (TSVT)
NASDAQ:TSVT
Holding TSVT?
Track your performance easily
TSVT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.54 - $6.40
Previous Close$5.05
Volume868.35K
Average Volume (3M)404.62K
Market Cap
$260.06M
Enterprise Value$309.59M
Total Cash (Recent Filing)$201.87M
Total Debt (Recent Filing)$251.40M
Price to Earnings (P/E)―
Beta2.25
Next Earnings
Nov 27, 2024EPS Estimate
-$0.27Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.06
Shares Outstanding51,497,928
10 Day Avg. Volume302,384
30 Day Avg. Volume404,622
Standard Deviation0.31
R-Squared0.09
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)1.11
Price to Sales (P/S)5.89
Price to Cash Flow (P/CF)-2.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.43
Enterprise Value/Gross Profit3.71
Enterprise Value/Ebitda-1.82
Forecast
1Y Price Target
$5.50Price Target Upside8.91% Upside
Rating ConsensusHold
Number of Analyst Covering4
2seventy bio News
PremiumCompany Announcements
2seventy bio Halts KarMMa-9 Study, Forecasts Strong Abecma Sales
PremiumCompany Announcements
2seventy bio Strikes Strategic Gene Therapy Deal with Novo Nordisk
Bulls Say, Bears Say
Bulls Say
Market ResonanceReported re-start of Abecma use in large academic medical centers is an important milestone, indicating resonance of the Abecma value proposition for some patients.
ProfitabilityPositive leading indicators for meaningful Abecma US sales growth could get 2seventy bio to consistent profitability.
Sales GrowthAbecma apheresis procedures have grown in the double-digits after US label expansion to 3L multiple myeloma.
Bears Say
Market CompetitionAbecma demand in the late line setting continues to be negatively affected by competition from Carvykti and bispecifics.
Market ShareThe company’s commercial outlook now hinges solely on Abecma, which is losing market share in the face of increasing competition from both Carvykti and bispecifics.
Sales GrowthGrowth sustainability of Abecma sales remains questionable beyond mid-decade.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
TSVT FAQ
What was 2seventy bio’s price range in the past 12 months?
2seventy bio lowest stock price was $1.53 and its highest was $6.40 in the past 12 months.
What is 2seventy bio’s market cap?
Currently, no data Available
When is 2seventy bio’s upcoming earnings report date?
2seventy bio’s upcoming earnings report date is Nov 27, 2024 which is in 24 days.
How were 2seventy bio’s earnings last quarter?
2seventy bio released its earnings results on Aug 07, 2024. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of -$0.666 by $1.116.
Is 2seventy bio overvalued?
According to Wall Street analysts 2seventy bio’s price is currently Undervalued.
Does 2seventy bio pay dividends?
2seventy bio does not currently pay dividends.
What is 2seventy bio’s EPS estimate?
2seventy bio’s EPS estimate is -$0.27.
How many shares outstanding does 2seventy bio have?
2seventy bio has 51,497,930 shares outstanding.
What happened to 2seventy bio’s price movement after its last earnings report?
2seventy bio reported an EPS of $0.45 in its last earnings report, beating expectations of -$0.666. Following the earnings report the stock price went up 8.209%.
Which hedge fund is a major shareholder of 2seventy bio?
Among the largest hedge funds holding 2seventy bio’s share is Baker Bros Advisors LP. It holds 2seventy bio’s shares valued at 10M.
---
2seventy bio Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$5.50 (8.91% Upside)
$5.50 (8.91% Upside)
Blogger Sentiment
Bullish
TSVT Sentiment 80%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 19.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $33.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.6%
Last 30 Days ▼ 3.0%
Last 30 Days ▼ 3.0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
47.23%
12-Months-Change
Fundamentals
Return on Equity
-51.89%
Trailing 12-Months
Asset Growth
-26.61%
Trailing 12-Months
Company Description
2seventy bio
2seventy bio Inc is primarely in the business of pharmaceutical preparations.
---
TSVT Earnings Call
Q2 2024
0:00 / 0:00
---
TSVT Stock 12 Month Forecast
Average Price Target
$5.50
▲(8.91% Upside)
Technical Analysis
Best Analysts Covering TSVT
1 Year
1 Year Success Rate
3/18 ratings generated profit
1 Year Average Return
-40.24%
reiterated a buy rating 3 months ago
Copying Daina Graybosch's trades and holding each position for 1 Year would result in 16.67% of your transactions generating a profit, with an average return of -40.24% per trade.
---